RxDoctor Payments Data

Peter Debelius-Enemark, MD

Psychiatry · Tallahassee, FLNPI 1376593913

Payments from drug & device makers

$1,735in general payments, 2019–2025

Across 93 payments — averaging $18.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$316
  • Alkermes, Inc.$228
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$210
  • E.r. Squibb & Sons, L.L.C.$143
  • Vanda Pharmaceuticals Inc.$132
  • Lundbeck LLC$97
  • plus $608 from 13 others

What the payments were for

  • Food & beverage$1,735100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,735 in reported general payments places this provider in the 65th percentile of 2,059 psychiatry providers in Florida.

See all psychiatry providers in Florida

Medicare billing

Part B allowed, 2024
$13,471
Medicare patients
39
Services billed
150

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole21$30,649
Lurasidone Hcl14$8,471
Lisdexamfetamine Dimesylate15$3,643
Venlafaxine Hcl ErVenlafaxine Hcl106$2,409
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl12$2,332
Lamotrigine190$2,091
Quetiapine Fumarate84$1,873
Perphenazine16$1,862
Lorazepam154$1,799
Aripiprazole75$1,721
Memantine Hcl80$1,474
Clonazepam184$1,461
Gabapentin46$1,247
Bupropion XlBupropion Hcl71$1,187
Duloxetine Hcl47$1,114

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$316$30,64921 claims
Almatica Pharma LLCSertraline Hcl$41$971137 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,059 psychiatry providers in Florida.

Other psychiatry in Tallahassee

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →